Viva BioInnovator is a venture capital firm that globally invests in early-stage biotech innovation, focusing on novel solutions for unmet medical needs across biopharmaceuticals, medical devices, diagnostics, and life science tools. Their strategy involves providing both financial investment and in-kind services, leveraging Viva Biotech's R&D expertise to accelerate the growth of their portfolio companies.
75% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months. Their most common stage is series-b (75% of deals). Average disclosed round size is $39.6M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Kainova Therapeutics | Series B | $32M | Feb 2026 |
 Fuse Biotherapeutics, Inc | Seed | $9.5M | Nov 2021 |
 DTx Pharma | Series B | $100M | Mar 2021 |
 Iterion Therapeutics | Series B | $17M | Feb 2021 |
Top Co-Investors
GPG Ventures1 shared
RA Capital Management1 shared
Access Biotechnology1 shared
Surveyor Capital1 shared
Cormorant Asset Management1 shared
Janus Henderson Investors1 shared
Logos Capital1 shared
Eli Lilly and Company1 shared
Panacea Venture1 shared
Schroders Capital1 shared
Investissement Quebec1 shared
3B Future Health Fund1 shared
adMare BioInnovations1 shared
Sherpa Healthcare Partners1 shared
Last updated: 21 April 2026